E715-0085 Screening compound: 1-{6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-yl}-N-(9-ethyl-9H-carbazol-3-yl)piperidine-3-carboxamide

E715-0085 Screening compound: 1-{6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-yl}-N-(9-ethyl-9H-carbazol-3-yl)piperidine-3-carboxamide
E715-0085 Screening compound: 1-{6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-yl}-N-(9-ethyl-9H-carbazol-3-yl)piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E715-0085
1-{6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-yl}-N-(9-ethyl-9H-carbazol-3-yl)piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E715-0085

Molecular Formula

C30H33N7O (C30 H33 N7 O)

Compound Name

1-{6H,7H,8H,9H,10H-azepino[2,1-h]purin-4-yl}-N-(9-ethyl-9H-carbazol-3-yl)piperidine-3-carboxamide

IUPAC name

1-{6H7H8H9H10H-azepino[21-h]purin-4-yl}-N-(9-ethyl-9H-carbazol-3-yl)piperidine-3-carboxamide

SMILES

CCn1c(ccc(NC(C(CCC2)CN2c2ncnc3c2nc2n3CCCCC2)=O)c2)c2c2c1cccc2

InChI

InChI=1S/C30H33N7O/c1-2-36-24-11-6-5-10-22(24)23-17-21(13-14-25(23)36)33-30(38)20-9-8-15-35(18-20)28-27-29(32-19-31-28)37-16-7-3-4-12-26(37)34-27/h5-6,10-11,13-14,17,19-20H,2-4,7-9,12,15-16,18H2,1H3,(H,33,38)/t20-/m0/s1

InChI Key

VQRUOUCGPWTXBZ-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD14911412

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

507.64

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.405

Distribution Coefficient, logD

5.399

Water Solubility, LogSw

-5.59

Polar Surface Area

60.320

Acid Dissociation Constant (pKa)

13.15

Base Dissociation Constant (pKb)

5.53

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.00

E715-0085 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E715-0085 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E715-0085?
Check Price and Availability of E715-0085, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E715-0085 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E715-0085
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E715-0085
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E715-0085 available by request